RenovoRx Inc. Revenue 2024–2025
RenovoRx Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- RenovoRx Inc. revenue for the quarter ending March 31, 2026 was 563000, a 185.79% increase year-over-year.
- RenovoRx Inc. revenue for the twelve months ending March 31, 2026 was 1.4 M.
- RenovoRx Inc. annual revenue for 2025 was 1.1 M, a 2511.63% increase from 2024.
- RenovoRx Inc. annual revenue for 2024 was 43000.
RenovoRx Inc. (RNXT) — Frequently Asked Questions
RenovoRx Inc. (RNXT) is a publicly traded US company. It has a market capitalization of $30M. In fiscal 2025 it reported revenue of $1M and net income of -$11M. Explore RNXT's stock price, financial statements, earnings history, margins and key ratios below.
What is RenovoRx Inc.'s market cap?
RenovoRx Inc. (RNXT) has a market capitalization of $30M.
What is the RNXT stock price?
RNXT trades at $0.85 (-1.08% on the day).
How much revenue does RenovoRx Inc. make?
RenovoRx Inc. reported revenue of $1M in fiscal 2025.
Is RNXT profitable?
In fiscal 2025, RenovoRx Inc. reported net income of -$11M.